id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0268-0004,FDA,FDA-2004-E-0268,"Certificate Extending Patent Term from U.S. Patent and Trademark Office to Birch, Stewart, Kolash & Birch, LLP",Rule,Certificate Extending Patent Term,2006-11-22T05:00:00Z,2006,11,,,2025-11-13T00:24:57Z,,0,0,09000064804721ed
FDA-2004-E-0268-0003,FDA,FDA-2004-E-0268,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-01-12T05:00:00Z,2006,1,,,2025-11-13T00:22:58Z,,0,0,09000064804721ec
FDA-2004-E-0268-0002,FDA,FDA-2004-E-0268,Determination of Regulatory Review Period for Purposes of Patent Extension; ERTACZO,Notice,General Notice,2005-05-19T04:00:00Z,2005,5,2005-05-12T04:00:00Z,2005-07-12T03:59:59Z,2025-11-13T00:20:22Z,05-9462,0,0,09000064804721eb
FDA-2004-E-0268-0006,FDA,FDA-2004-E-0268,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2005-04-19T04:00:00Z,2005,4,,,2025-11-13T00:28:58Z,,0,0,09000064804721ef
FDA-2004-E-0268-0005,FDA,FDA-2004-E-0268,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-09-02T04:00:00Z,2004,9,,,2025-11-13T00:27:06Z,,0,0,09000064804721ee
FDA-2004-E-0268-0001,FDA,FDA-2004-E-0268,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2004-07-15T04:00:00Z,2004,7,,,2025-11-24T18:35:23Z,,0,0,09000064804721e8